Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-09-17
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483415, A61K 31415, C07D23364
Patent
active
055568726
ABSTRACT:
The present invention provides histamine derivatives and methods for using histamine derivatives as immunomodulators and in immunotherapeutics. More specifically the present invention provides methods for inhibiting at least a portion of an an antigen specific antibody response and/or a portion of a T-cell proliferative response by the immune system of a mammal comprising administering to said mammal an effective amount of a composition comprising at least one histamine derivative having binding specificity for at least one histamine receptor.
REFERENCES:
patent: 2988478 (1961-06-01), Gordon
patent: 4333946 (1982-06-01), Durant et al.
patent: 4340596 (1982-07-01), Furukawa et al.
patent: 4532331 (1985-07-01), Frazee et al.
patent: 4687873 (1987-08-01), Goodman et al.
patent: 4837305 (1989-06-01), Goodman et al.
patent: 4996221 (1991-02-01), Melmon et al.
Rudinger, J. "Characteristics of the amino acids as components of a peptide hormone sequence" in Peptide Hormones Parsons, J. A. ed., Univ. Park Press (1976) pp. 1-7.
Khan, et al. "The Effects of Autacoids on Cloned Murine Lymphoid Cells: Modulation of IL-2 Secretion and the Activity of Natural Suppressor Cells" J. Immunol. 134:4100-4106 (1985).
Khan, et al. "The Effects of Derivatives of Histamine on Natural Suppressor Cells" J. Immunol. 137:308-314 (1986).
Qiu, et al. "Effects of Histamine-Trifluoromethyl-Toluidide Derivative (HTMT) on Intracellular Calcium in Human Lymphocytes", J. Pharmacology and Experimental Therapeutics 253:1245-1251 (1990).
Melmon, K. L. and Khan, M. M. "Considering Receptor Non-Specificity as a Factor for Developing Effect, Tissue, and Receptor Specific Agents" in Enzymes as Targets for Drug Design, pp. 45-57, Academic Press (1990).
Khan et al. Proc West Phamacol. Soc 30 (1987) pp. 383-387.
Khan et al. J. Med. Chem 30 Noll, (1987) pp. 2115-2120.
Khan, et al., "Congener Derivatives and Conjugates of Histamine: Synthesis and Tissue . . . ", J. Med. Chem., 1987, vol. 30, pp. 2115-2120.
Khan, et al., "Receptor and Tissue Specific Derivatives of Histamine: Novel Imune Modulators", Proc. West. Pharmacol. Soc., vol. 30, 1987, vol. 383-387.
Goodman Murray
Khosropour Parisa
Melmon Kenneth L.
Ambrose Michael G.
Richter Johann
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Histamine derivatives useful as immunomodulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine derivatives useful as immunomodulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine derivatives useful as immunomodulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413423